We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

U.S. High Court Won’t Rule If Drug Maker Has Duty To Monitor Drug Study Patients

(October 1, 2018, 12:00 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on Oct. 1 said it will not review a California state appeals court ruling that overturned a $5.6 million Risperdal death verdict, preserving a...
To view the full article, register now.